Medtronic plc MDT
NYSE · XNYS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1977-11-21
Chart by TradingView
7/9
Piotroski F — financial health
3.75
Altman Z″ — distress risk · safe
75.8%
Dividend payout · stretched
Valuation · market cap as of 2026-06-29
Market cap$103.7B
P / E21.6×
P / S2.9×
P / B2.1×
P / FCF19.1×
Dividend yield3.51%
Financials & ratios (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $36.4B | $33.5B | $32.4B | $31.2B | $31.7B |
| Operating income | $6.5B | $6.0B | $5.1B | $5.5B | $5.8B |
| Net income | $4.8B | $4.7B | $3.7B | $3.8B | $5.0B |
| Operating cash flow | $7.3B | $7.0B | $6.8B | $6.0B | $7.3B |
| Free cash flow | $5.4B | $5.2B | $5.2B | $4.6B | $6.0B |
| Total assets | $93.0B | $91.7B | $90.0B | $90.9B | $91.0B |
| Total liabilities | $43.0B | $43.4B | $39.6B | $39.3B | $38.3B |
| Shareholders' equity | $49.5B | $48.3B | $50.4B | $51.7B | $52.7B |
| Ratios | |||||
| Operating margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.2% |
| Net margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% |
| FCF margin | 14.9% | 15.5% | 16.1% | 14.7% | 18.9% |
| Return on assets | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% |
| Return on equity | 9.7% | 9.7% | 7.3% | 7.3% | 9.6% |
| Current ratio | 2.13 | 1.85 | 2.03 | 2.39 | 1.86 |
| Revenue growth | 8.4% | 3.6% | 3.6% | -1.4% | 5.2% |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 3.75 (safe)
- Working capital / assets 0.141
- Retained earnings / assets 0.351
- EBIT / assets 0.07
- Equity / liabilities 1.151
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001613103 · as of 2026-04-24. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.